{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T07:59:54Z","timestamp":1773388794238,"version":"3.50.1"},"reference-count":86,"publisher":"American Society for Microbiology","issue":"7","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Clin Vaccine Immunol"],"published-print":{"date-parts":[[2016,7]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>A promising concept for human immunodeficiency virus (HIV) vaccines focuses immunity on the highly conserved transition state structures and epitopes that appear when the HIV glycoprotein gp120 binds to its receptor, CD4. We are developing chimeric antigens (full-length single chain, or FLSC) in which gp120 and CD4 sequences are flexibly linked to allow stable intrachain complex formation between the two moieties (A. DeVico et al., Proc Natl Acad Sci U S A 104:17477\u201317482, 2007, doi:<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/dx.doi.org\/10.1073\/pnas.0707399104\">10.1073\/pnas.0707399104<\/jats:ext-link>; T. R. Fouts et al., J Virol 74:11427\u201311436, 2000,<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/dx.doi.org\/10.1128\/JVI.74.24.11427-11436.2000\">doi:10.1128\/JVI.74.24.11427-11436.2000<\/jats:ext-link>). Proof of concept studies with nonhuman primates show that FLSC elicited heterologous protection against simian-human immunodeficiency virus (SHIV)\/simian immunodeficiency virus (SIV) (T. R. Fouts et al., Proc Natl Acad Sci U S A 112:E992\u2013E999, 2016,<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/dx.doi.org\/10.1073\/pnas.1423669112\">doi:10.1073\/pnas.1423669112<\/jats:ext-link>), which correlated with antibodies against transition state gp120 epitopes. Nevertheless, advancement of any vaccine that comprises gp120-CD4 complexes must consider whether the CD4 component breaks tolerance and becomes immunogenic in the autologous host. To address this, we performed an immunotoxicology study with cynomolgus macaques vaccinated with either FLSC or a rhesus variant of FLSC containing macaque CD4 sequences (rhFLSC). Enzyme-linked immunosorbent assay (ELISA) binding titers, primary CD3<jats:sup>+<\/jats:sup>T cell staining, and temporal trends in T cell subset frequencies served to assess whether anti-CD4 autoantibody responses were elicited by vaccination. We find that immunization with multiple high doses of rhFLSC did not elicit detectable antibody titers despite robust responses to rhFLSC. In accordance with these findings, immunized animals had no changes in circulating CD4<jats:sup>+<\/jats:sup>T cell counts or evidence of autoantibody reactivity with cell surface CD4 on primary naive macaque T cells. Collectively, these studies show that antigens using CD4 sequences to stabilize transition state gp120 structures are unlikely to elicit autoimmune antibody responses, supporting the advancement of gp120-CD4 complex-based antigens, such as FLSC, into clinical testing.<\/jats:p>","DOI":"10.1128\/cvi.00115-16","type":"journal-article","created":{"date-parts":[[2016,5,19]],"date-time":"2016-05-19T02:53:20Z","timestamp":1463626400000},"page":"618-627","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":8,"title":["An HIV gp120-CD4 Immunogen Does Not Elicit Autoimmune Antibody Responses in Cynomolgus Macaques"],"prefix":"10.1128","volume":"23","author":[{"given":"Jennifer A.","family":"Schwartz","sequence":"first","affiliation":[{"name":"Profectus Biosciences, Inc., Baltimore, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilia","family":"Prado","sequence":"additional","affiliation":[{"name":"Profectus Biosciences, Inc., Baltimore, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johnathan","family":"Misamore","sequence":"additional","affiliation":[{"name":"BIOQUAL, Inc., Rockville, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah","family":"Weiss","sequence":"additional","affiliation":[{"name":"BIOQUAL, Inc., Rockville, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesse","family":"Francis","sequence":"additional","affiliation":[{"name":"Advanced Bioscience Laboratory, Inc., Rockville, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ranajit","family":"Pal","sequence":"additional","affiliation":[{"name":"Advanced Bioscience Laboratory, Inc., Rockville, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Huaman","sequence":"additional","affiliation":[{"name":"Advanced Bioscience Laboratory, Inc., Rockville, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony","family":"Cristillo","sequence":"additional","affiliation":[{"name":"Advanced Bioscience Laboratory, Inc., Rockville, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George K.","family":"Lewis","sequence":"additional","affiliation":[{"name":"Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert C.","family":"Gallo","sequence":"additional","affiliation":[{"name":"Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony L.","family":"DeVico","sequence":"additional","affiliation":[{"name":"Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy R.","family":"Fouts","sequence":"additional","affiliation":[{"name":"Profectus Biosciences, Inc., Baltimore, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1413550111"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1586\/14760584.2016.1129905"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1089\/088922201316912808"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature01470"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005369"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12977-016-0241-5"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.07139-11"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M112.399402"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2014.04.025"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0707399104"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(02)00080-4"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.74.24.11427-11436.2000"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004772"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/384179a0"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1038\/384184a0"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.2174\/157016207782418560"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.3390\/v7092856"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02194-14"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.2174\/1570162X113116660059"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00171-11"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1423669112"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.aab3886"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature10766"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2013.09.061"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.2174\/1570162X113116660056"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01023-12"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1113425"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.182412199"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1996.0188"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0075665"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3007730"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1586\/14760584.2014.951335"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2015.10.014"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1038\/348411a0"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02533-09"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20042510"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000171"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01896-09"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.4155\/bio.13.6"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-013-9468-4"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jim.2015.01.003"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kev277"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.4155\/bio.14.114"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1586\/ecp.11.39"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2015.1048411"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2015.03.002"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2003.169"},{"key":"e_1_3_2_49_2","first-page":"220","article-title":"CD4 coating, but not CD4 depletion, is a predictor of efficacy with primatized monoclonal anti-CD4 treatment of active rheumatoid arthritis","volume":"29","author":"Mason U","year":"2002","unstructured":"Mason U, Aldrich J, Breedveld F, Davis CB, Elliott M, Jackson M, Jorgensen C, Keystone E, Levy R, Tesser J, Totoritis M, Truneh A, Weisman M, Wiesenhutter C, Yocum D, Zhu J. 2002. CD4 coating, but not CD4 depletion, is a predictor of efficacy with primatized monoclonal anti-CD4 treatment of active rheumatoid arthritis. J Rheumatol 29:220\u2013229.","journal-title":"J Rheumatol"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1159\/000060506"},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.1053\/sarh.2001.27736"},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199304000-00007"},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199803150-00006"},{"key":"e_1_3_2_54_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199403270-00002"},{"key":"e_1_3_2_55_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199203000-00001"},{"key":"e_1_3_2_56_2","doi-asserted-by":"publisher","DOI":"10.1089\/aid.1992.8.1091"},{"key":"e_1_3_2_57_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-198810000-00004"},{"key":"e_1_3_2_58_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199002000-00003"},{"key":"e_1_3_2_59_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199105000-00014"},{"key":"e_1_3_2_60_2","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.4049\/jimmunol.149.6.2194","article-title":"Analysis of HIV-induced autoantibodies to cryptic epitopes on human CD4","volume":"149","author":"Callahan LN","year":"1992","unstructured":"Callahan LN, Roderiquez G, Mallinson M, Norcross MA. 1992. Analysis of HIV-induced autoantibodies to cryptic epitopes on human CD4. J Immunol 149:2194\u20132202.","journal-title":"J Immunol"},{"key":"e_1_3_2_61_2","doi-asserted-by":"publisher","DOI":"10.1089\/aid.1992.8.1919"},{"key":"e_1_3_2_62_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199403000-00017"},{"key":"e_1_3_2_63_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-2478(94)90127-9"},{"key":"e_1_3_2_64_2","doi-asserted-by":"publisher","DOI":"10.1089\/aid.1996.12.273"},{"key":"e_1_3_2_65_2","doi-asserted-by":"publisher","DOI":"10.1089\/088922299310377"},{"key":"e_1_3_2_66_2","doi-asserted-by":"publisher","DOI":"10.1089\/088922200309458"},{"key":"e_1_3_2_67_2","doi-asserted-by":"publisher","DOI":"10.1016\/0090-1229(91)90156-5"},{"key":"e_1_3_2_68_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-198810000-00003"},{"key":"e_1_3_2_69_2","doi-asserted-by":"publisher","DOI":"10.2131\/jts.28.109"},{"key":"e_1_3_2_70_2","doi-asserted-by":"publisher","DOI":"10.1101\/gr.123117.111"},{"key":"e_1_3_2_71_2","doi-asserted-by":"publisher","DOI":"10.3109\/1547691X.2011.631610"},{"key":"e_1_3_2_72_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2009.03.012"},{"key":"e_1_3_2_73_2","doi-asserted-by":"publisher","DOI":"10.1093\/ilar\/ilt043"},{"key":"e_1_3_2_74_2","doi-asserted-by":"publisher","DOI":"10.4331\/wjbc.v3.i4.73"},{"key":"e_1_3_2_75_2","doi-asserted-by":"publisher","DOI":"10.1089\/aid.1993.9.431"},{"key":"e_1_3_2_76_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.75.22.11096-11105.2001"},{"key":"e_1_3_2_77_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1217609110"},{"key":"e_1_3_2_78_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.65.1.489-493.1991"},{"key":"e_1_3_2_79_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.72.6.4694-4703.1998"},{"key":"e_1_3_2_80_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.66.9.5635-5641.1992"},{"key":"e_1_3_2_81_2","volume-title":"Guidance for Industry: S8 immunotoxicity studies for human pharmaceuticals","author":"US Food and Drug Administration","year":"2006","unstructured":"US Food and Drug Administration. 2006 Guidance for Industry: S8 immunotoxicity studies for human pharmaceuticals. US Food and Drug Administration, Rockville, MD."},{"key":"e_1_3_2_82_2","doi-asserted-by":"publisher","DOI":"10.1089\/aid.1997.13.1461"},{"key":"e_1_3_2_83_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-2478(96)02553-9"},{"key":"e_1_3_2_84_2","first-page":"269","article-title":"Anti-CD4 activity of normal human immunoglobulin G for therapeutic use (intravenous immunoglobulin, IVIg)","volume":"1","author":"Hurez V","year":"1994","unstructured":"Hurez V, Kaveri SV, Mouhoub A, Dietrich G, Mani JC, Klatzmann D, Kazatchkine MD. 1994. Anti-CD4 activity of normal human immunoglobulin G for therapeutic use (intravenous immunoglobulin, IVIg). Ther Immunol 1:269\u2013277.","journal-title":"Ther Immunol"},{"key":"e_1_3_2_85_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.88.11.4616"},{"key":"e_1_3_2_86_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.88.1.120"},{"key":"e_1_3_2_87_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.89.11.5103"}],"container-title":["Clinical and Vaccine Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CVI.00115-16","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CVI.00115-16","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T07:57:06Z","timestamp":1692345426000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/CVI.00115-16"}},"subtitle":[],"editor":[{"given":"H. F.","family":"Staats","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":86,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["10.1128\/CVI.00115-16"],"URL":"https:\/\/doi.org\/10.1128\/cvi.00115-16","relation":{},"ISSN":["1556-6811","1556-679X"],"issn-type":[{"value":"1556-6811","type":"print"},{"value":"1556-679X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"2016-03-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-05-11","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-07-05","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}